Cytological and molecular diagnosis of lymphoma

Journal of Clinical Pathology

Volumn 58, Issue 6, 2005, Pages 561-567

  Kocjan, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ASPIRATION CYTOLOGY; CANCER CYTODIAGNOSIS; CANCER STAGING; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOLOGY; DNA MICROARRAY; EXCISION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOMA; MEDICAL DECISION MAKING; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; CHROMOSOME ABERRATION; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; NEEDLE BIOPSY; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY;

BIOPSY, FINE-NEEDLE; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, NON-HODGKIN; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 20444448972     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.019133     Document Type: Review

References (90)

1. Spagnolo DV, Ellis DW, Juneja S, et al. The role of molecular studies in lymphoma diagnosis: a review. Pathology 2004;36:19-44.
2. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
3. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project. Blood 1997;89:3909-18.
4. Jaffe ES, Banks PM, Nathwani B, et al. Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod Pathol 2004;17:131-5.
5. Migliazza A, Bosch F, Komatsu H, et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001;97:2098-104.
6. Gaidano G, Newcomb EW, Gong JZ, et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994;144:1312-19.
7. Offit K, Parsa NZ, Filippa D, et al. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 1992;80:2594-9.
8. Iida S, Rao PH, Nallasivam P, et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996;88:4110-17.
9. Morrison AM, Nutt SL, Thevenin C, et al. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. Semin Immunol 1998;10:133-42.
10. Jiang W, Kahn SM, Zhou P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993;8:3447-57.
11. Fan H, Gulley ML, Gascoyne RD, et al. Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas. Diagn Mol Pathol 1998;7:209-14.
12. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
13. Gaidano G, Hauptschein RS, Parsa NZ, et al. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 1992;80:1781-7.
14. Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993;82:2289-95.
15. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-9.
16. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45.
17. Gascoyne RD. Molecular pathogenesis of mucosal-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2003;44(suppl 3):S13-20.
18. Papavasiliou FN, Schatz DG. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 2000;408:216-21.
19. Dalla-Favera RGG. Principles and practice in oncology. Philadelphia: Lippincot Williams & Wilkins, 2001.
20. Klangby U, Okan I, Magnusson KP, et al. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 1998;91:1680-7.
21. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-4.
22. Stein H, Foss HD, Durkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000;96:3681-95.
23. Das DK. Value and limitations of fine-needle aspiration cytology in diagnosis and classification of lymphomas: a review. Diagn Cytopathol 1999;21:240-9.
24. Daskalopoulou D, Harhalakis N, Maouni N, et al. Fine needle aspiration cytology of non-Hodgkin's lymphomas. A morphologic and immunophenotypic study. Acta Cytol 1995;39:180-6.
25. Soderlund V, Tani E, Skoog L, et al. Diagnosis of skeletal lymphoma and myeloma by radiology and fine needle aspiration cytology. Cytopathology 2001;12:157-07.
26. Liu ES, Bernstein JM, Sculerati N, et al. Fine needle aspiration biopsy of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol 2001;60:135-40.
27. Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol 2004;22:3046-52.
28. Lioe TF EH, Allen DC, Spence RA. The role of fine needle aspiration cytology (FNAC) in the investigation of superficial lymphadenopathy; uses and limitations of the technique. Cytopathology 1999;10:291-7.
29. Kocjan G. The role of FNAC in diagnosis of lymph node enlargements. Cytopathology 1997;8(suppl):2-3.
30. Young NA, Al-Saleem T. Diagnosis of lymphoma by fine-needle aspiration cytology using the revised European-American classification of lymphoid neoplasms. Cancer 1999;87:325-45.
31. Dong HY, Harris NL, Preffer FI, et al. Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry. Mod Pathol 2001;14:472-81.
32. Liu K, Mann KP, Vitellas KM, et al. Fine-needle aspiration with flow cytomelric immunophenotyping for primary diagnosis of intra-abdominal lymphomas. Diagn Cytopathol 1999;21:98-104.
33. Young NA, Al-Saleem TI, Ehya H, et al. Utilization of fine-needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma. Cancer 1998;84:252-61.
34. Henrique RM, Sousa ME, Godinho MI, et al. Immunophenotyping by flow cytometry of fine needle aspirates in the diagnosis of lymphoproliferative disorders: a retrospective study. J Clin Lab Anal 1999;13:224-8.
35. Meda BA, Buss DH, Woodruff RD, et al. Diagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined Fine-needle aspiration cytomorphology and flow cytometry. Am J Clin Pathol 2000;113:688-99.
36. Bellido M, Rubiol E, Ubeda J, et al. Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells. Eur J Haematol 2001;66:100-6.
37. Gong JZ, Snyder MJ, Lagoo AS, et al. Diagnostic impact of core-needle biopsy on fine-needle aspiration of non-Hodgkin lymphoma. Diagn Cytopathol 2004;31:23-30.
38. Mourad WA, al Nazer M, Tulbah A. Cytomorphologic differentiation of Hodgkin's lymphoma and Ki-1+anaplastic large cell lymphoma in fine needle aspirates. Acta Cytol 2003;47:744-8.
39. Katz R. Pitfalls in the diagnosis of fine-needle aspiration of lymph nodes. Monogr Pathol 1997;39:118-33.
40. Mourad WA, Tulbah A, Shoukri M, et al. Primary diagnosis and REAL/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2003;28:191-5.
41. Sun W, Caraway NP, Zhang HZ, et al. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index. Acta Cytol 2004;48:119-26.
42. Hans CP, Weisenburger DD, Vose JM, et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 2003;101:2363-7.
43. Landgren O, Porwit MacDonald A, Tani E, et al. A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. Hematol J 2004;5:69-76.
44. Medeiros U, Carr J. Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med 1999;123:1189-207.
45. Langerak AW, van Krieken JH, Wolvers-Tettero IL, et al. The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders. J Clin Pathol 2001;54:565-7.
46. Vega F, Medeiros LJ. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med 2003;127:1148-60.
47. Hui P, Howe JG, Crouch J, et al. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leuk Lymphoma 2003;44:1385-94.
48. Jeffers MD MJ, Farquharson MA, Stewart CJ, et al. Analysis of clonality in cytologic material using the polymerase chain reaction (PCR). Cytopathology 1997;8:114-21.
49. Salto-Tellez M, Zhang D, Chiu LL, et al. Immunocytochemistry versus molecular fingerprinting of metastases. Cytopathology 2003;14:186-90.
50. Alkan S LC, Sarago C, Sidawy MK, et al. Polymerase chain reaction detection of immunoglobulin gene rearrangement and bcl-2 translocation in archival glass slides of cytologic material. Diagn Mol Pathol 1995;4:25-31.
51. Aiello A DD, Giardini R, Alasio L, et al. PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal. Diagn Mol Pathol 1997;6:154-60.
52. van Dangen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
53. Sun T, Nordberg ML, Cotelingam JD, et al. Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma. Am J Hematol 2003;74:78-84.
54. Fan YS, Rizkalla K. Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis. A summary of 154 cases. Cancer Genet Cytogenet 2003;143:73-9.
55. Vaandrager JW, Schuuring E, Raap T, et al. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 2000;27:85-94.
56. Gong Y, Caraway N, Gu J, et al. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer 2003;99:385-93.
57. Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol 2002;11:47-57.
58. Fiegl M, Haun M, Massoner A, et al. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol 2004;22:474-83.
59. Kraan J, von Bergh AR, Kleiverda K, et al. Multicolor fiber FISH. Methods Mol Biol 2002;204:143-53.
60. Kim MH, Stewart J, Devlin C, et al. The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes. Cancer Genet Cytogenet 2001;126:26-33.
61. Lestou VS, Gascoyne RD, Sehn L, et al. Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome. Br J Haematol 2003;122:745-59.
62. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-97.
63. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003;102:3871-9.
64. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
65. Lim EH, Aggarwal A, Agasthian T, et al. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers. Clin Cancer Res 2003;9:5980-7.
66. Assersohn L, Gangi L, Zhao Y, et al. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. Clin Cancer Res 2002;8:794-801.
67. Sotiriou C, Powles TJ, Dowsett M, et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 2002;4:R3.
68. Symmans WF, Ayers M, Clark EA, et al. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 2003;97:2960-71.
69. Haralambieva E, Banham AH, Bastard C, et al. Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples. Br J Haematol 2003;121:49-56.
70. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003;348:1777-85.
71. Basso K, Liso A, Tiacci E, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med 2004;199:59-08.
72. Wiestner A, Staudt LM. Towards molecular diagnosis and targeted therapy of lymphoid malignancies. Semin Hematol 2003;40:296-307.
73. Fenton JA, Vaandrager JW, Aarts WM, et al. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood 2002;99:716-18.
74. Isaacson PG, Du MQ. AMLT lymphoma: from morphology to molecules. Nat Rev Cancer 2004;4:644-53.
75. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944-51.
76. Hamblin TJ. Predicting progression-ZAP-70 in CLL. N Engl J Med 2004;351:856-7.
77. Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363:105-11.
78. Iqbal J, Sanger WG, Horsman DE, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004;165:159-66.
79. de Leval L, Harris NL. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. Histopathology 2003;43:509-28.
80. Telatar M, Grody WW, Emmanouilides C. Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis. Mol Diagn 2001;6:161-8.
81. Ladetto M, Mantoan B, Ricca I, et al. Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. Exp Hematol 2003;31:784-8.
82. Druker BJ TM, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7.
83. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
84. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002;8:68-74.
85. de Jong D, van't Veer LJ. Tools for molecular risk-stratification for clinical purposes: CLL as a prototype. Eur J Hum Genet 2004;12:423.
86. Wright G, Tan B, Rosenwald A, et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2003;100:9991-6.
87. Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol 2002;29:258-63.
88. Sheils O, O'Leary J. Quality control issues for PCR-based assays in the molecular laboratory. Curr Diagn Pathol 2003;9:155-8.
89. Levine PH, Zamuco R, Yee HT. Role of fine-needle aspiration cytology in breast lymphoma. Diagn Cytopathol 2004;30:332-40.
90. Becich MJ. The role of the pathologist as tissue refiner and data miner: the impact of functional genomics on the modern pathology laboratory and the critical roles of pathology informatics and bioinformatics. Mol Diagn 2000;5:287-99.